David Fagjenbaum, MD

Physician-Scientist, University of Pennsylvania

David Fajgenbaum, MD, MBA, MSc, is a groundbreaking physician-scientist at the University of Pennsylvania where he is one of the youngest individuals ever appointed to the faculty, co-Founder & President of the Castleman Disease Collaborative Network, and national bestselling author of 'Chasing My Cure: A Doctor's Race to Turn Hope Into Action'. He is also a patient battling a deadly disease which he discovered a treatment for that is saving his life and others. He currently leads a public-private initiative to apply his drug repurposing approach to discover treatments for many more diseases and serves on the Board of Directors for the Reagan-Udall Foundation for the FDA. 

Fajgenbaum has published scientific papers in high-impact journals such as the New England Journal of Medicine and Lancet, been recognized with awards such as the 2016 Atlas Award which he received along with then Vice President Joe Biden, and profiled in a New York Times cover story as well as by Good Morning America, CNN, Forbes 30 Under 30, and the Today Show. Dr. Fajgenbaum earned a BS from Georgetown University, MSc from the University of Oxford, MD from the University of Pennsylvania, and MBA from The Wharton School.